Effectiveness of whey proteins for the treatment of atopic dermatitis: A pilot study.

Phase 1

Completed

• Conditions: Atopic Dermatitis; Skin - Dermatological conditions; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12614000635662
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Presence of atopic dermatitis according to physician diagnosis using SCORAD

Exclusion Criteria

1is lactose intolerant
2consumes fish oil, probiotics, prebiotics, whey protein supplements during the trial period
3requires insulin use (for treatment of diabetes)
4has history of liver, kidney or thyroid disease
5uses anti-inflammatory or immune-modulating medications
6has heavy alcohol consumption
7is pregnant or intends to become pregnant

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of eczema symptoms measured by SCORAD (SCORing Atopic Dermatitis). SCORAD is a clinical tool used to assess the extent and severity of eczema. It is validated for determining severity of eczema and will be utilised by a consultant dermatologist.[Scoring will occur at baseline and then every two weeks for eight weeks (day 56) followed by further assessment four weeks after supplementation]